NEOGEN2026-07-012026-09-30NEOGEN2026-09-30NEOGEN2026-03-31NEOGEN2026-04-012026-09-30NEOGEN2026-07-012026-09-30in-capmkt:OtherExpenses1MemberNEOGEN2026-04-012026-09-30in-capmkt:OtherExpenses1MemberNEOGEN2026-09-30OtherNoncurrentFinancialAssetsDomain1NEOGEN2026-09-30OtherNoncurrentAssetsDomain1NEOGEN2026-09-30OtherCurrentFinancialAssetsDomain1NEOGEN2026-09-30OtherCurrentAssetsDomain1NEOGEN2026-09-30OtherNoncurrentFinancialLiabilitiesDomain1NEOGEN2026-09-30OtherNoncurrentFinancialLiabilitiesDomain2NEOGEN2026-09-30OtherCurrentFinancialLiabilitiesDomain1NEOGEN2026-09-30OtherCurrentFinancialLiabilitiesDomain2NEOGEN2026-09-30OtherCurrentLiabilitiesDomain1NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain1NEOGEN2026-06-30RelatedPartyTransactionDomain1NEOGEN2026-09-30RelatedPartyTransactionDomain1NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain2NEOGEN2026-06-30RelatedPartyTransactionDomain2NEOGEN2026-09-30RelatedPartyTransactionDomain2NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain3NEOGEN2026-06-30RelatedPartyTransactionDomain3NEOGEN2026-09-30RelatedPartyTransactionDomain3NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain4NEOGEN2026-06-30RelatedPartyTransactionDomain4NEOGEN2026-09-30RelatedPartyTransactionDomain4NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain5NEOGEN2026-06-30RelatedPartyTransactionDomain5NEOGEN2026-09-30RelatedPartyTransactionDomain5NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain6NEOGEN2026-06-30RelatedPartyTransactionDomain6NEOGEN2026-09-30RelatedPartyTransactionDomain6NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain7NEOGEN2026-06-30RelatedPartyTransactionDomain7NEOGEN2026-09-30RelatedPartyTransactionDomain7NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain8NEOGEN2026-06-30RelatedPartyTransactionDomain8NEOGEN2026-09-30RelatedPartyTransactionDomain8NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain9NEOGEN2026-06-30RelatedPartyTransactionDomain9NEOGEN2026-09-30RelatedPartyTransactionDomain9NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain10NEOGEN2026-06-30RelatedPartyTransactionDomain10NEOGEN2026-09-30RelatedPartyTransactionDomain10NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain11NEOGEN2026-06-30RelatedPartyTransactionDomain11NEOGEN2026-09-30RelatedPartyTransactionDomain11NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain12NEOGEN2026-06-30RelatedPartyTransactionDomain12NEOGEN2026-09-30RelatedPartyTransactionDomain12NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain13NEOGEN2026-06-30RelatedPartyTransactionDomain13NEOGEN2026-09-30RelatedPartyTransactionDomain13NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain14NEOGEN2026-06-30RelatedPartyTransactionDomain14NEOGEN2026-09-30RelatedPartyTransactionDomain14NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain15NEOGEN2026-06-30RelatedPartyTransactionDomain15NEOGEN2026-09-30RelatedPartyTransactionDomain15NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain16NEOGEN2026-06-30RelatedPartyTransactionDomain16NEOGEN2026-09-30RelatedPartyTransactionDomain16NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain17NEOGEN2026-06-30RelatedPartyTransactionDomain17NEOGEN2026-09-30RelatedPartyTransactionDomain17NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain18NEOGEN2026-06-30RelatedPartyTransactionDomain18NEOGEN2026-09-30RelatedPartyTransactionDomain18NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain19NEOGEN2026-06-30RelatedPartyTransactionDomain19NEOGEN2026-09-30RelatedPartyTransactionDomain19NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain20NEOGEN2026-06-30RelatedPartyTransactionDomain20NEOGEN2026-09-30RelatedPartyTransactionDomain20NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain21NEOGEN2026-06-30RelatedPartyTransactionDomain21NEOGEN2026-09-30RelatedPartyTransactionDomain21NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain22NEOGEN2026-06-30RelatedPartyTransactionDomain22NEOGEN2026-09-30RelatedPartyTransactionDomain22NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain23NEOGEN2026-06-30RelatedPartyTransactionDomain23NEOGEN2026-09-30RelatedPartyTransactionDomain23NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain24NEOGEN2026-06-30RelatedPartyTransactionDomain24NEOGEN2026-09-30RelatedPartyTransactionDomain24NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain25NEOGEN2026-06-30RelatedPartyTransactionDomain25NEOGEN2026-09-30RelatedPartyTransactionDomain25NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain26NEOGEN2026-06-30RelatedPartyTransactionDomain26NEOGEN2026-09-30RelatedPartyTransactionDomain26NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain27NEOGEN2026-06-30RelatedPartyTransactionDomain27NEOGEN2026-09-30RelatedPartyTransactionDomain27NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain28NEOGEN2026-06-30RelatedPartyTransactionDomain28NEOGEN2026-09-30RelatedPartyTransactionDomain28NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain29NEOGEN2026-06-30RelatedPartyTransactionDomain29NEOGEN2026-09-30RelatedPartyTransactionDomain29NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain30NEOGEN2026-06-30RelatedPartyTransactionDomain30NEOGEN2026-09-30RelatedPartyTransactionDomain30NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain31NEOGEN2026-06-30RelatedPartyTransactionDomain31NEOGEN2026-09-30RelatedPartyTransactionDomain31NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain32NEOGEN2026-06-30RelatedPartyTransactionDomain32NEOGEN2026-09-30RelatedPartyTransactionDomain32NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain33NEOGEN2026-06-30RelatedPartyTransactionDomain33NEOGEN2026-09-30RelatedPartyTransactionDomain33NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain34NEOGEN2026-06-30RelatedPartyTransactionDomain34NEOGEN2026-09-30RelatedPartyTransactionDomain34NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain35NEOGEN2026-06-30RelatedPartyTransactionDomain35NEOGEN2026-09-30RelatedPartyTransactionDomain35NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain36NEOGEN2026-06-30RelatedPartyTransactionDomain36NEOGEN2026-09-30RelatedPartyTransactionDomain36NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain37NEOGEN2026-06-30RelatedPartyTransactionDomain37NEOGEN2026-09-30RelatedPartyTransactionDomain37NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain38NEOGEN2026-06-30RelatedPartyTransactionDomain38NEOGEN2026-09-30RelatedPartyTransactionDomain38NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain39NEOGEN2026-06-30RelatedPartyTransactionDomain39NEOGEN2026-09-30RelatedPartyTransactionDomain39NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain40NEOGEN2026-06-30RelatedPartyTransactionDomain40NEOGEN2026-09-30RelatedPartyTransactionDomain40NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain41NEOGEN2026-06-30RelatedPartyTransactionDomain41NEOGEN2026-09-30RelatedPartyTransactionDomain41NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain42NEOGEN2026-06-30RelatedPartyTransactionDomain42NEOGEN2026-09-30RelatedPartyTransactionDomain42NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain43NEOGEN2026-06-30RelatedPartyTransactionDomain43NEOGEN2026-09-30RelatedPartyTransactionDomain43NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain44NEOGEN2026-06-30RelatedPartyTransactionDomain44NEOGEN2026-09-30RelatedPartyTransactionDomain44NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain45NEOGEN2026-06-30RelatedPartyTransactionDomain45NEOGEN2026-09-30RelatedPartyTransactionDomain45NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain46NEOGEN2026-06-30RelatedPartyTransactionDomain46NEOGEN2026-09-30RelatedPartyTransactionDomain46NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain47NEOGEN2026-06-30RelatedPartyTransactionDomain47NEOGEN2026-09-30RelatedPartyTransactionDomain47NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain48NEOGEN2026-06-30RelatedPartyTransactionDomain48NEOGEN2026-09-30RelatedPartyTransactionDomain48NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain49NEOGEN2026-06-30RelatedPartyTransactionDomain49NEOGEN2026-09-30RelatedPartyTransactionDomain49NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain50NEOGEN2026-06-30RelatedPartyTransactionDomain50NEOGEN2026-09-30RelatedPartyTransactionDomain50NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain51NEOGEN2026-06-30RelatedPartyTransactionDomain51NEOGEN2026-09-30RelatedPartyTransactionDomain51NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain52NEOGEN2026-06-30RelatedPartyTransactionDomain52NEOGEN2026-09-30RelatedPartyTransactionDomain52NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain53NEOGEN2026-06-30RelatedPartyTransactionDomain53NEOGEN2026-09-30RelatedPartyTransactionDomain53NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain54NEOGEN2026-06-30RelatedPartyTransactionDomain54NEOGEN2026-09-30RelatedPartyTransactionDomain54NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain55NEOGEN2026-06-30RelatedPartyTransactionDomain55NEOGEN2026-09-30RelatedPartyTransactionDomain55NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain56NEOGEN2026-06-30RelatedPartyTransactionDomain56NEOGEN2026-09-30RelatedPartyTransactionDomain56NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain57NEOGEN2026-06-30RelatedPartyTransactionDomain57NEOGEN2026-09-30RelatedPartyTransactionDomain57NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain58NEOGEN2026-06-30RelatedPartyTransactionDomain58NEOGEN2026-09-30RelatedPartyTransactionDomain58NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain59NEOGEN2026-06-30RelatedPartyTransactionDomain59NEOGEN2026-09-30RelatedPartyTransactionDomain59NEOGEN2026-07-012026-09-30RelatedPartyTransactionDomain60NEOGEN2026-06-30RelatedPartyTransactionDomain60NEOGEN2026-09-30RelatedPartyTransactionDomain60NEOGEN2026-07-012026-09-30AuditorDomain1NEOGEN2026-09-30Statement1NEOGEN2026-07-012026-09-30Statement1NEOGEN2026-09-30StatementDynamic1I1Statement1NEOGEN2026-09-30StatementDynamic1I2Statement1NEOGEN2026-09-30StatementDynamic1I3Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares542665NEOGENNOTLISTEDINE136S01016Neogen Chemicals LimitedMain BoardEquity2026-04-012027-03-312026-10-312026-10-28INRCroresQuarterlySecond quarterSingle segmentSpecialty Chemicals2026-10-3114:31:002026-10-3119:00:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2026-02-11https://neogenchem.com/wp-content/uploads/Policy-on-Materiality-of-Related-Party-Transactions-and-Dealing-with-Related-Party-Transactions-1.pdftrue1falseNot Applicable2026-07-012026-09-30UnauditedStandalone28800000008280000029628000002210100000168400000-707600000229800000265500000701000004422000002678500000284300000028430000062800000101000007290000002114000000000211400000-8000000203400000300200000107.67.6007.67.6Additional disclosures pursuant to regulation 52(4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended: <br /> <br /> Security coverage ratio has been determined at company level considering total loan availed by the company over total identified movable and immovable assets of the company on which charge is created. NCD of Rs. 200.00 Crore and term loan of Rs. 20.00 Crore raised from another lender are having Subservient charge over immovable assets at Karakhadi and Dahej and all the movable assets of the company. <br /> Pursuant to SEBI Operational Circular for Issue and Listing of Non-Convertible Securities, Securitized Debt Instruments, Security Receipts, Municipal Debt Securities and Commercial Paper dated May 22, 2024, as amended from time to time, the Company has listed Non- Convertible Debentures (NCDs) on BSE Limited (BSE). <br /> The Company is rated by leading credit rating agency Crisil Ratings Limited ("Crisil"). Crisil has downgraded the rating on July 17,2026 to "Crisil A2+" from "Crisil A1"and "Crisil A-/Negative" from "Crisil A/Negative" for its short-term facilities and long-term facilities (including NCDs) respectively. Pursuant to the rating downgrade the coupon rate of the said NCDs of Rs. 200 crore has increased from 10.50% p.a. to 11.00% p.a. effective from July 17, 2026. Crisil has revised Outlook from negative to stable as on September 25,2026 for its long-term facilities. <br /> 2. The above unaudited financial results of the Company for the quarter and half year ended September 30, 2026 have been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the other accounting principles generally accepted in India and are in compliance with the disclosure requirement of Regulations 33 and Regulations 52 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 as amended and were reviewed by the Statutory Auditor and recommended by the Audit Committee in its meeting held on October 31, 2026, to the Board for approval and was approved by the Board of Directors at their meeting held on October 31, 2026. <br /> <br /> 3. During the quarter and half year ended September 30, 2026, the Company completed a Qualified Institutions Placement (“QIP”) in accordance with Chapter VI of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable provisions. Pursuant to the QIP, the Company allotted 26,60,753 equity shares of face value Rs.10 each at an issue price of Rs. 2255 per equity share, including a securities premium of Rs. 2245 per share, to eligible qualified institutional buyers. The issue was completed on September 16,2026, aggregating to gross proceeds of Rs. 600 Crore. After deducting issue-related expenses of Rs. 20 Crore, the net proceeds amounted to Rs. 580 Crore. The proceeds are proposed to be utilised towards Repayment/ pre-payment, in full or part, of certain borrowings; Funding our long-term working capital requirements and General corporate purposes, in accordance with the placement document. During the quarter, an amount of Rs.230.35 was utilised towards the aforesaid objects, and the balance unutilised proceeds as at 30 September,2026 amounted to Rs.349.65. Consequent to the allotment, the paid-up equity share capital of the Company increased by Rs. 2.66 Crore, and the securities premium account increased by Rs.597.34, before considering any applicable adjustments for issue expenses. <br /> <br /> 4. On March 05, 2025, there was fire at Multi-Purpose Plant (MPP3) Facility, Tank Farms and warehouse at Dahej SEZ Plant of the Company. This incident led to damage of certain property, plant and equipment, inventory and interrupted business. The Company is adequately insured for reinstatement value of damaged fixed assets, inventory and loss of profits due to business interruption. The Company has intimated the fire incident with the insurance company and submitted loss estimate pertaining to replacement value of the damaged property, plant and equipment, loss of damaged inventory and incidental expenses incurred on account of fire. The Claim is admitted by the insurance company. <br /> <br /> During the financial year ended March 31, 2025, the Company has recognised loss of Rs. 348.16 Crore on account of damage to certain property, plant & equipment, inventory and estimated cost of incidental charges. The Company has recognised insurance claim receivable of Rs. 334.60 Crore to the extent of recovery of loss after adjusting applicable deductibility considering its assessment of loss and admissibility of claims as per the policy, adequacy of coverage and nature of loss and based upon the independent opinion obtained by the company from Independent Surveyor and Independent Expert Practitioner. The Company has not accounted claim for loss of profit due to business interruption and excess value of reinstatement of assets over written down value as per accounting conservatism. The aforementioned losses and corresponding insurance claim has been presented on a net basis of Rs. 13.56 Crore under exceptional item and claim receivable in other current financial assets in these standalone financial results for the financial year ended March 31, 2025. <br /> <br /> The Company has received Rs. 164.49 Crore (Rs. 155.00 Crore as on account payment from insurance company and balance Rs. 9.49 Crore pertains to sale of scrap) and incurred further incidental charges of Rs. 1.41 Crore which is also claimed as per insurance policy upto September 30,2026. Accordingly, net claim receivable as on September 30, 2026 is Rs. 171.52 Crore. <br /> <br /> Subsequent to the quarter ended September 30,2026, The Insurance company has approved for an additional claim amount of Rs.. 152.00 crore to be released in due course of time, as part payment out of the entire claim receivable. <br /> <br /> <br /> 5. The Board of Directors of the Company, at its meeting held on March 7, 2026, inter alia approved the issue and offer of 10,00,000 equity shares of face value of Rs. 10 each at a price of Rs. 1,610 per Equity Share including a premium of Rs. 1,600 per Equity Share, aggregating to Rs. 1,61,00,00,000 (Rupees One Hundred and Sixty One Crore only) on preferential basis for cash consideration. Subsequently, the shareholders of the Company at its Extra Ordinary General meeting (EGM) held on March 29, 2026, has approved issue, offer and allotment of the said 10,00,000 equity shares to Cadamba Solutions Private Limited, a Promoter Group member of the Company. The allotment of the said equity shares of the Company on a preferential basis was done on April 18, 2026. The Equity Shares were listed on BSE Limited and National Stock Exchange of India Limited. <br /> <br /> Further we hereby confirm that there have been no deviations in the use of proceeds of issue of equity shares on preferential basis from the objects stated in the Notice dated March 7, 2026 for EGM held on March 29,2026 read with corrigendum to the said notice of EGM dated March 17, 2026 , for the quarter ended June 30,2026 and the intimation in this regard is being made available at https://neogenchem.com/announcements/ under the tab issue of securities and at the website of BSE Limited at https://www.bseindia.com/stock-share-price/neogen-chemicals-ltd/neogen/542665 and of National Stock exchange of India Limited at https://www.nseindia.com/get-quote/equity/NEOGEN/Neogen-Chemicals-Limited . <br /> <br /> 6. During the quarter and half year ended September 30, 2026, the Company has subscribed and been allotted Unsecured Compulsorily Convertible Debentures (“CCDs”) amounting to Rs. 45 Crore and Rs. 159 Crore of Neogen Ionics Limited (“wholly owned subsidiary”) respectively. <br /> <br /> 7. Previous period / year's figures have been regrouped / rearranged wherever necessary to make them comparable with the current period's classification. <br /> <br /> 8. The Company deals in Specialty Chemicals and considering that the nature of products and the predominant risk and returns of the products are similar, the Company considers it as one operating segment in accordance with Ind AS 108. <br /> <br /> 9. The above unaudited standalone financial results under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter and half year ended September 30, 2026 are available at the Company's website at https://necgenchem.com/financial-performance/, https://neogenchem.com/annual-reports-2/ and Stock Exchange's website at www.nseindia.com and www.bseindia.com. <br /> 2026-04-012026-09-30UnauditedStandalone540280000016180000055646000003975400000243400000-1115400000443900000496500000138300000837000000501910000054550000005455000001230000001670000013970000004058000000000405800000-66000003992000003002000001014.7514.750014.7514.75Other expenses442200000Other expenses837000000303420000023118000000049000000004677900000024081000001734000007259400000103800000127141000007128300000026868000003539700000100000340000026516000008881600000107350000017083400000297975000003002000001600110000016301300000163013000006508000006204000001271200000126900000212500000016106000006854000000141900000382670000039686000008478000001167040000011510000049500000506000001188560000001349620000029797500000Other non current financial assets173400000Other non-current assets103800000Other current financial assets2651600000Other current assets1073500000Lease liabilities596200000Other non-current financial liabilities24200000Lease liabilities207700000Other current financial liabilities640100000Other current liabilities115100000496500000-16119000008637000000-246400000-62800000-57000001019000000-2486000000-17220000011200000138300000000800000500000-1160000001273000000000-1090000037000000-880800000-3353000000001258000000-4611000000159000000000000001090100000927000000000000000001606000000300000000000998000000174400000-3619200000007414500000030200000000137210000060660000010320000027400000429600000007589600000350930000003509300000304000003539700000107000008800000-2700000-2200000-8000000-6600000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionCorporate Guarantee Fees (Income)Approved1730000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionESOP ExpensesApproved90000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryInvestmentApproved0118200000136400000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryInterest receivedApproved86600000980000014300000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionInter Corporate Deposit GivenApproved130600000010998000002405800000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionInvestment in Compulsory convertible debenturesApproved159000000029350000004525000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionApplication money Paid - Pending allotment of Compulsory convertible debenturesApproved-35000000350000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryPurchase of goods or servicesApproved4470000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiarySale of goods or servicesApproved457700000074700000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionRecovery of expenses (Income)Approved141500000370000064200000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionPayment on behalf of Neogen Ionics LimitedApproved230000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeApproved80000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionReceipt of lease rentApproved870000000Neogen Chemicals Limited******Neogen Ionics Limited******Wholly Owned SubsidiaryAny other transactionCorporate Guarantee Given on behalf of counter partyApproved01223000000012230000000Neogen Chemicals Limited******Neogen Chemicals Japan Corporation Limited******Wholly Owned SubsidiaryInvestmentApproved01190000011900000Neogen Chemicals Limited******Neogen Chemicals Japan Corporation Limited******Wholly Owned SubsidiaryAny other transactionRe-imbursement of expenses (Expenses)Approved11200000870000013300000Neogen Chemicals Limited******Neogen Chemicals Japan Corporation Limited******Wholly Owned SubsidiaryAny other transactionRecovery of expenses (Income)Approved000Neogen Chemicals Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionRecovery of expenses (Income)Approved0600000400000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureInterest received100000000Approved50000000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureAny other transactionShare of profit100000000Approved210000000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureInvestment100000000Approved050000007400000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureAny other transactionLoan given100000000Approved030000003000000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VenturePurchase of goods or services100000000Approved1500000016000005300000Neogen Chemicals Limited******Dhara Fine Chem Industries******Joint VentureSale of goods or services100000000Approved100000023000001200000Neogen Chemicals Limited******Kagashin Global network private limited******A private Company wherein a Director of the Company is acting as a DirectorPurchase of goods or services11400000Approved1140000042000002200000Neogen Chemicals Limited******Kagashin Global network private limited******A private Company wherein a Director of the Company is acting as a DirectorAny other transactionRe-imbursement of expenses11400000Approved180000000Cadamba Solutions Pvt Ltd******Neogen Chemicals Limited******A private Company wherein a Director of the Company is acting as a DirectorInvestmentApproved161000000001610000000Neogen Chemicals Limited******Avi Sabavala******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Chemicals Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Chemicals Limited******Manojkumar Pati******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Chemicals Limited******Rajeshkumar Shah******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Chemicals Limited******Manojkumar Pati******Independent DirectorAny other transactionCommission PaidApproved100000020000001000000Neogen Chemicals Limited******Avi Sabavala******Independent DirectorAny other transactionCommission PaidApproved300000500000300000Neogen Chemicals Limited******Rajeshkumar Shah******Independent DirectorAny other transactionCommission PaidApproved100000020000001000000Neogen Chemicals Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionCommission PaidApproved300000500000300000Neogen Chemicals Limited******Haridas Kanani******ChairmanRemunerationApproved000Neogen Chemicals Limited******Unnati Kanani******Company Secretary and Compliance OfficerRemunerationApproved2700000200000200000Neogen Chemicals Limited******Gopikrishnan Sarathy******CFORemunerationApproved12100000800000700000Neogen Chemicals Limited******Shyamsunder Upadhyay******Whole time DirectorRemunerationApproved8200000700000600000Neogen Chemicals Limited******Dr. Harin Kanani******Managing DirectorRemunerationApproved7600000300000700000Neogen Chemicals Limited******Triplicane Commandor Narsimhan Sai Krishnan******Executive DirectorRemunerationApproved131000008000001000000Neogen Chemicals Limited******Unnati Kanani******Company Secretary and Compliance OfficerAny other transactionESOP Expenses against shares granted but not vestedApproved100000100000200000Neogen Chemicals Limited******Gopikrishnan Sarathy******CFOAny other transactionESOP Expenses against shares granted but not vestedApproved4000006000001000000Neogen Chemicals Limited******Shyamsunder Upadhyay******Whole time DirectorAny other transactionESOP Expenses against shares granted but not vestedApproved5000008000001300000Neogen Chemicals Limited******Triplicane Commandor Narsimhan Sai Krishnan******Executive DirectorAny other transactionESOP Expenses against shares granted but not vestedApproved5000008000001300000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryInvestmentApproved100110000010000001002100000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryInterest receivedApproved420000013000005100000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionInter Corporate Deposit GivenApproved210000006600000087000000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionRent IncomeApproved600000075000000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionNet asset transfer under business transfer agreementApproved245000000001504500000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiarySale of goods or servicesApproved950000009900000Neogen Ionics Limited******Neogen Morita New Materials Limited******Wholly Owned SubsidiaryAny other transactionRecovery of expenses (Income)Approved440000000Neogen Ionics Limited******Cadamba Solutions Pvt Ltd******A private Company wherein a Director of the Company is acting as a DirectorInterest paid620000000Approved71000003000003700000Neogen Ionics Limited******Cadamba Solutions Pvt Ltd******A private Company wherein a Director of the Company is acting as a DirectorAny other transactionInter Corporate Deposit Received / (Repayment)620000000Approved-4920000005920000001000000Neogen Ionics Limited******Sanjay Mehta******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Ionics Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionSitting FeesApproved20000000Neogen Ionics Limited******Hitesh Reshamwala******Independent DirectorAny other transactionSitting FeesApproved10000000Neogen Ionics Limited******Hitesh Reshamwala******Independent DirectorAny other transactionCommission PaidApproved100000020000001000000Neogen Ionics Limited******Sanjay Mehta******Independent DirectorAny other transactionCommission PaidApproved100000020000001000000Neogen Ionics Limited******Prof. Ranjan Malik******Independent DirectorAny other transactionCommission PaidApproved3000005000003000008337200000UnauditedfalseM/s. Chandabhoy & Jassoobhoy, Chartered Accountantstrue2029-10-31QIP2026-09-1660000000002026-09-30trueCRISIL Ratings LimitedfalseNot ApplicableNot ApplicableNot ApplicableGopikrishnan SarathyChief Financial OfficerThane2026-10-31Repayment/ pre-payment, in full or part, of certain borrowings availed by the CompanyNA26500000000357000000Funding long-term working capital requirementsNA1750000000016307000000General corporate purposesNA140000000006371000000 *The amount utilized for general corporate purpose did not exceed 25% of the Gross proceeds. <br /> <br /> Note: Out of the total gross proceeds of Rs. 600 crore, estimated funds to be utilised towards issue related expenses (includes fees, commission and expenses of the Issue) is Rs. 20 crore of which Rs.18.52 crore was utilised towards issue related expenses during the quarter ended September 30, 2026.